Management of Dyspnea in Advanced Cancer

Publication Date: January 31, 2021
Last Updated: March 14, 2022

Recommendations

Screening and assessment

1.1. Clinicians should perform systematic assessment of dyspnea at every inpatient and outpatient encounter in patients with advanced cancer using validated patient-reported outcome measures.
(good practice statement)
6539
1.2. For patients who are unable to self-report, clinicians should use a validated observation measure.
(good practice statement)
6539
1.3. Whenever possible, patients with dyspnea should undergo a comprehensive evaluation for the severity, chronicity, potential causes, triggers, and associated symptoms, as well as emotional and functional impact.
(good practice statement)
6539

Overview

Title

Management of Dyspnea in Advanced Cancer

Authoring Organization

American Society of Clinical Oncology